VITAMIN D metabolism , Marshall protocol , CYP24 in PFS and CFS

Helen

Well-Known Member
Staff member
Messages
5,415
We know that many people in PFS have very low vitamin D levels and high levels of active vitamin D -1.25D . It would be nice if people tested this in different oxidations. So we can see the differences


Here is the Marshall protocol and explanation of this.

The Marshall Protocol is a medical treatment being used by physicians worldwide to treat a variety of chronic inflammatory and autoimmune diseases including (but not limited to) sarcoidosis, Chronic Fatigue Syndrome, fibromyalgia, Crohn’s Disease, and rheumatoid arthritis. While other treatments for chronic disease use palliative medications in an effort to cover up symptoms, the Marshall Protocol is a curative treatment, which strives to address the root cause of the disease process.
Information about the treatment can be found at the study site,marshallprotocol.com and also at autoimmunityresearch.org. The site is run by the staff of the Autoimmunity Research Foundation, a California-based non-profit agency. Over 200 health professionals are members of the site, and discussions are moderated by volunteer moderators. There is no charge to use the website or the treatment and all patients are welcome to participate.
The FDA has already granted orphan product designations for two of Autoimmunity Research Foundation’s six applications – Sarcoidosis, and Post Treatment Lyme Disease Syndrome (PTLDS, commonly known as chronic Lyme). The Foundation continues to work with the FDA to make effective therapies available in an even wider array of chronic diagnoses.
Chronic Disease
The Marshall Protocol is based on the hypothesis that chronic diseases (termed Th1 illnesses), are the result of infection by an intraphagocytic, metagenomic microbiota of chronic bacterial forms that are often referred to as the Th1 pathogens. The term intraphagocytic refers to the fact that these bacteria have developed the ability to remain alive and proliferate undetected inside the cytoplasm of the cells they infect. These cells include macrophages, the very cells of the immune system that the body uses to kill invading pathogens. Once inside these cells, they cause our own cells to release inflammatory cytokines (proteins that often generate pain and/or fatigue).
The term metagenomic indicates that there is a tremendous number of different species of these chronic bacterial forms. Finally, the term microbiota refers to the fact that these bacteria are also hypothesized to sustain themselves by grouping into communities called biofilms. The bacteria inside a biofilm produce a protective matrix that allows them to more effectively evade the immune system and develop resistance to antibiotics.
Many of the Th1 pathogens are also postulated to be in a chronic state referred to as the L-form. L-form bacteria simply represent part of the natural life cycles of classical bacteria. Under certain conditions, they mutate from classical bacteria, losing their cell walls in the process. Although researchers have known about L-form bacteria for over a century, up until recently they have not fully understood their role in causing chronic disease. Because they lack a cell wall, many antibiotics are unable to kill them directly and they cannot be detected by standard laboratory tests.
The ability of the Th1 pathogens to proliferate in the body is directly related to the vitamin D receptor (VDR). Critically important to the body, the Vitamin D Receptor (VDR) controls the innate immune system – the body’s first line of defense against infection. It’s also responsible for turning on/off a wide array of genes and chemical pathways. One of the VDR’s myriad jobs is to control expression of several families of antimicrobial peptides (AMPs), proteins that kill bacteria, viruses and fungi by a variety of mechanisms including disrupting membranes, interfering with metabolism, and targeting components of the machinery inside the cell.
Although casually referred to as a vitamin by some members of the medical community, molecular biologists have long realized that the precursor form of vitamin D (25-D) is really a secosteroid. Recent molecular modeling research (which has been confirmed by a large amount of clinical data) has shown that levels of 25-D over 20 ng/ml can bind and inactivate the VDR, which subsequently shuts down the innate immune system.
Certain species of bacteria also produce substances that can bind and inactivate the VDR in a manner similar to 25-D. Consequently, people who are infected with the Th1 pathogens and consuming vitamin D are no longer able to produce the AMPs or turn on the innate immune response. This allows their bacteria to proliferate and spread.
When the innate immune system can no longer function, people have a very hard time keeping other pathogens under control. They often find that childhood viral infections reactivate, or that they acquire Candida (pathogenic yeast) and Mycoplasma as well. Thus, every person who starts the MP has a different mix of pathogens to kill depending on what microbes they have encountered during various stages of life. A person’s unique mix of pathogens is often referred to as their “toxigenic pea soup.”
Research indicates that the Th1 pathogens have evolved mechanisms that allow them to both mutate and alter the expression of the genes inside the cells they infect. These effects on the genes result in changes in the cellular environment that make it easier for new pathogens to invade the cell – creating a snowball effect where, as a person acquires more pathogens, it becomes even easier for them to pick up a diverse array of other infectious agents. This process is known as successive infection.
Since the Th1 pathogens have been shown to survive in the sperm and egg, and evidence is growing that they can also pass through the placental barrier, they can be passed from parent to child – meaning that Th1 illnesses often run in families. In addition, the bacterial forms may be easily passed by human contact to an infant soon after birth, during the period before the adaptive immune system is up and running.
Unlike its inactive counterpart, 25-D, that inactivates the VDR in healthy individuals, 1,25-D binds and activates the VDR. But in individuals who have 25-D and bacterial proteins blocking the VDR, 1,25-D is forced out of the receptor and into the surrounding environment.
Furthermore, in healthy individuals, the VDR transcribes an enzyme called CYP24. CYP24 breaks down excess 1,25-D, ensuring that the level of 1,25-D in the body stays in the normal range. But in chronically ill individuals, the VDR (which is blocked by bacterial susbstances) can no longer transcribe CYP24. The level of 1,25-D in the body becomes significantly elevated since there is no CYP24 to keep it in check.
Another enzyme called CYP27B1 normally regulates the amount of 25-D converted into 1,25-D. When more CYP27B1 is produced, conversion occurs at a greater rate. The cytokines released by the immune system in response to the Th1 pathogens activate a protein called Protein Kinase A (PKA). PKA in turn activates CYP27B1, causing more 25-D to be converted to 1,25-D.
These processes cause 1,25-D to rise to an unnaturally high level. Unfortunately, when 1,25-D reaches a certain threshold, it binds not just the VDR, but many of the body’s other nuclear receptors, displacing the metabolites that are meant to be in the receptors under normal conditions.
The nuclear receptors affected by 1,25-D are receptors that regulate the body’s hormones – the glucocorticoid receptor, and the alpha and beta thyroid receptors, the adrenal receptors, and the progesterone receptors, among others.
This means that when 1,25-D is high, it competitively displaces cortisol, T3, and other metabolites from their target nuclear receptors, causing havoc on the body’s hormonal pathways. Thus, most people with chronic disease find they have difficulty tolerating stress, changes in temperature, and a variety of other hormone-related issues. Also, when levels of 1,25-D rise above 42 ng/ml, calcium begins to be leached from the bones, a process that results in osteoporosis and osteopenia.
When 1,25-D rises due to the processes described above, it also binds a receptor called the PXR. The PXR subsequently inhibits conversion of pre-vitamin D to 25-D, causing 25-D levels to drop. This means that low levels of 25-D – the form of vitamin D measured by most doctors – is not a sign of vitamin D deficiency. Instead, low levels of 25-D are a result of the disease process.
The body also produces 1,25-D in response to sunlight on the skin and bright light in the eyes. Excessive exposure to these sources of light helps drive the disease process. Most patients on the MP must take certain precautions, described on the web site, to avoid too much sun/bright light.
The Treatment
Patients on the Marshall Protocol take a medication called olmesartan (called Benicar in the United States), which is able to bind and activate the VDR by pushing 25-D and bacterial proteins out of the receptor. Patients also lower levels of 25-D in the body by avoiding the kinds of vitamin D present in various foods. These measures renew the body’s ability to turn on the innate immune system and produce the anti microbial peptides. The immune system is then able to kill the Th1 pathogens and is once again able to manage viral and other co-infections.
At the same time, MP patients take pulsed, low-dose antibiotics. Antibiotics taken in this manner are much more effective against bacteria in biofilms and are able to greatly weaken the Th1 pathogens so that the patient’s own immune system is then able to destroy them. The antibiotics weaken the bacteria by blocking their ribosomes, which they need to produce proteins that help them survive and reproduce. It’s important to understand that when the Th1 pathogens die, there is a temporary change in a patient’s immunopathology.
Immunopathology refers to the changes in the immune system that result from bacterial death (another term sometimes used is the Jarisch-Herxheimer or “Herx” reaction). Dying bacteria release toxins into the bloodstream, stimulate the production of inflammatory cytokines, and generate temporary hormonal imbalances. This means that once patients begin the MP, each dose of antibiotic will cause them to feel bad for the period of time it takes their immune system to deal with the consequences of bacterial die-off.
Before starting the MP, many people may feel that they have improved through consuming vitamin D and taking steroids such as prednisone. In reality, these compounds further inactivate the VDR, preventing the immune system from effectively killing the Th1 pathogens. Since it is the death of these forms of bacteria that generates an increase in painful symptoms, people may experience short-term relief when using vitamin D or prednisone as their immune system shuts down and fewer bacteria are killed. However, in reality, this situation allows the bacteria to spread more easily.
Applicable Illnesses
Patients on the MP have dozens of different medical conditions. As evidenced by members’ reported progress on the marshallprotocol.com website, nearly all experience a powerful immunopathological reaction after taking a dose of antibiotics.
Many patients report great improvement, while some are approaching complete recovery.
Some of the diseases patients are currently using the MP to treat include (but are not limited to):
  • Sarcoidosis
  • Chronic Fatigue Syndrome
  • Fibromyalgia
  • Chronic Lyme Disease
  • Rheumatoid Arthritis
  • Multiple Chemical Sensitivity (MCS)
  • Myasthenia gravis
  • Psoriasis
  • Osteoarthritis
  • Hashimoto’s Thyroiditis
  • Uveitis
  • Cardiac Arrhythmia

About the Marshall Protocol


In my opinion this protocol desensitized VDR. and not the opposite. and stops calcium absorption which then increases metabolic rate and kills pathogens.

Would be interesting to see. or hear anyone who tried this. @bruschi11
 
Last edited:

Helen

Well-Known Member
Staff member
Messages
5,415
Now another possibility why this happens is the lack of CYP24 enzyme

CYP24A1 - Wikipedia

Vitamin D3 24-hydroxylase - Wikipedia


So as we can see, it is IRON CYSTEINE enzyme with NADPH as a cofactor.


As we know cysteine could be totally down since we know that all folate enzymes and methylation is GONE in PFS according to the tests.


this can decrease break down of 1.25D and also totally kill androgen receptor binding to ARE
 
Last edited:

Helen

Well-Known Member
Staff member
Messages
5,415
Also here is the connection with Androgen Receptor ( AR) and VDR

Androgen receptor AR suppressed VDR. So in some cases it could block VDR and raise 1.25D

Androgen Receptor Regulation of Vitamin D Receptor in Response of Castration-Resistant Prostate Cancer Cells to 1α-Hydroxyvitamin D5: A Calcitriol Analog


So if androgen receptors is overexpressed, this kills VDR and stops you from retaining calcium.

We have seen this happen in about 50% cases on our POIS forum.

Zero calcium levels. and no sperm.( calcium)
 
Last edited:

Helen

Well-Known Member
Staff member
Messages
5,415
I have been dealing with many people in PFS. some of them have very low calcium non existant in blood, like in my case. but my 1.25D was high. overexpressed AR is suppressing VDR.

and some of them have very high calcium and high 1.25D also.( usually slow oxidizers) probably because of lack of break down by CYP24



I have a neigbour who is PSSD, and slow oxidizer. very high calcium on hair. slow oxidizer, PSSD


If calcium is constantly retained, this slows down thyroid. and body raises progesterone to retain potassium. to fight this.

When progesterone is RAISED, this wastes all your sodium. into the urine. Since sodium is low. then sensitivity of adrenaline is very low in the cell, since sodium makes adrenaline work better. And thus Magnesium is also lost since magnesium slows down adrenaline. And that would be bad.

So body has to ramp up adrenaline production, thus there is tons of activation of dopamine into adrenaline.


So because 1.25 is high , this retains calcium , retains potassium, wastes sodium, and gets rid of magnesium. and all of this increases dopamine to noradrenaline and adrenaline conversion, since sodium is being wasted. and sensitivity of adrenaline is low in the cell.


SO as an idea, if slow oxidizers some how increase break down of 1.25D hormone, by CYP24 enzyme. then this lowers calcium in blood.

and body stops potassium absorbtion by lowering progesterone, the minute progesterone goes down, sodium goes back up.

the minute sodium goes up, adrenaline activation stops. and magnesium goes into the cell.



My neighbour did feel better on magnesium and potassium etc , but he has been taking them for years, and it did nothing for his PSSD, since calcium activation never stopped. So it does not matter that you are taking these things. calcium keeps going in .
 

jinstewart

Well-Known Member
Messages
189
Last edited:

Helen

Well-Known Member
Staff member
Messages
5,415
So it could be that fast oxidizers, have no calcium since they cant absorb it , since AR is blocking VDR

and slow oxidizers, have too much of 1.25 D , since they cant break down, since their methylation is impaired( no cysteine) , or GABA receptor is overexpressed which tells the body to retain calcium.


This is why sodium butyrate is part of the regimen
 

Ocguy

Well-Known Member
Messages
417
So it could be that fast oxidizers, have no calcium since they cant absorb it , since AR is blocking VDR

and slow oxidizers, have too much of 1.25 D , since they cant break down, since their methylation is impaired( no cysteine) , or GABA receptor is overexpressed which tells the body to retain calcium.


This is why sodium butyrate is part of the regimen

Butyrate to feed/enhance the microbiome?
 

bruschi11

Administrator
Staff member
Messages
3,011
That’s what I’m talking about @Helen ! Good stuff.

Talked about this a little bit in early 2017 when i was all effed up on solvepfs. Ordered the pills and never used them. Damn I doubt I could find them at this point.

@Moonman looked into this and I don’t think he ever ran it. Would be interesting to see someone try it.
 

brix

Well-Known Member
Messages
593
So it could be that fast oxidizers, have no calcium since they cant absorb it , since AR is blocking VDR

and slow oxidizers, have too much of 1.25 D , since they cant break down, since their methylation is impaired( no cysteine) , or GABA receptor is overexpressed which tells the body to retain calcium.


This is why sodium butyrate is part of the regimen

What happens when a fast oxidizer has upper limit serum calcium? My vit D is also upper range.
 

tanedout

Well-Known Member
Messages
538
Good find @Helen !

This makes a LOT of sense. Many people feel better taking vitamin D (including myself, and I think I've overdone it and ended up retaining too much calcium as a result), but some people on the PAS threads have felt pretty much recovered on vitamin D, and I can think of at least one who was 100% recovered on high dose Prednisone, but when he stopped taking it he slowly went back into PAS, and it's not safe to take Prednisone long term.

It's a shame this protocol involves pharmaceuticals. Would be good if there was a herbal alternative.
 

Benedict

Member
Messages
14
I always have bad reaction to vitamin D supplements, i was using two differents brands and have extreme anxiety and weakness from it, dont know why, searching on google i find that can be low magnesium, but even after taking magnesium things dont become better, and my vitamin d levels are very low,